Drug profile

The FDA adverse-event record for Amoxicillin Clavulanate

37 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Amoxicillin Clavulanate. See the species affected, top reactions, and outcomes below.

37
adverse-event reports
21.6%
death-coded share
Dog
most-reported species
8
Neutrophilia - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
37
Total Reports
8
Deaths Reported
21.6%
Death Rate

Active Ingredients

Amoxicillin Clavulanate

Administration Routes

OralUnknown

Species Affected

Dog 33
Cat 4

Most Affected Breeds

Retriever - Labrador 6
Terrier - Bull - American Pit 4
Domestic Shorthair 3
Shepherd Dog - German 3
Bulldog - French 2
Retriever - Golden 2
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 2
Shar Pei 2
Terrier - Jack Russell 1
Terrier - Boston 1

Most Reported Reactions

Neutrophilia 8
Leucocytosis NOS 8
Fever 7
Abnormal radiograph finding 6
Lack of efficacy - NOS 6
Lethargy (see also Central nervous system depression in Neurological) 6
Anaemia NOS 6
Death 5
Anorexia 5
Polydipsia 5
Unable to stand 5
Intentional misuse 5

Outcome Breakdown

Ongoing
22 (59.5%)
Died
5 (13.5%)
Recovered/Normal
4 (10.8%)
Outcome Unknown
3 (8.1%)
Euthanized
3 (8.1%)

Amoxicillin Clavulanate Adverse Event Insights

37 reports name Amoxicillin Clavulanate; 8 recorded a death outcome (21.6% of reported events, not a population-level mortality rate). Active ingredient: Amoxicillin Clavulanate. Administration routes: Oral, Unknown.

By species: Dog (33 reports), Cat (4 reports). By breed: Retriever - Labrador (6), Terrier - Bull - American Pit (4), Domestic Shorthair (3).

Leading clinical signs: Neutrophilia (8), Leucocytosis NOS (8), Fever (7), Abnormal radiograph finding (6). Outcome, 37 coded reports: Ongoing leads at 59.5%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.